nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—Cloperastine—Dimenhydrinate—atopic dermatitis	0.389	0.678	CrCrCtD
Flavoxate—CHRM2—Dimenhydrinate—atopic dermatitis	0.186	0.672	CbGbCtD
Flavoxate—Cloperastine—Diphenhydramine—atopic dermatitis	0.185	0.322	CrCrCtD
Flavoxate—CHRM2—Diphenhydramine—atopic dermatitis	0.0906	0.328	CbGbCtD
Flavoxate—Drowsiness—Diphenhydramine—atopic dermatitis	0.00175	0.0218	CcSEcCtD
Flavoxate—Drowsiness—Dimenhydrinate—atopic dermatitis	0.00175	0.0218	CcSEcCtD
Flavoxate—Skin disorder—Desonide—atopic dermatitis	0.00148	0.0185	CcSEcCtD
Flavoxate—Drowsiness—Loratadine—atopic dermatitis	0.00135	0.0168	CcSEcCtD
Flavoxate—Tension—Dimenhydrinate—atopic dermatitis	0.00134	0.0167	CcSEcCtD
Flavoxate—Tension—Diphenhydramine—atopic dermatitis	0.00134	0.0167	CcSEcCtD
Flavoxate—Nervousness—Diphenhydramine—atopic dermatitis	0.00133	0.0165	CcSEcCtD
Flavoxate—Nervousness—Dimenhydrinate—atopic dermatitis	0.00133	0.0165	CcSEcCtD
Flavoxate—Vision blurred—Dimenhydrinate—atopic dermatitis	0.00129	0.016	CcSEcCtD
Flavoxate—Vision blurred—Diphenhydramine—atopic dermatitis	0.00129	0.016	CcSEcCtD
Flavoxate—Vertigo—Diphenhydramine—atopic dermatitis	0.00123	0.0153	CcSEcCtD
Flavoxate—Vertigo—Dimenhydrinate—atopic dermatitis	0.00123	0.0153	CcSEcCtD
Flavoxate—Palpitations—Dimenhydrinate—atopic dermatitis	0.00121	0.015	CcSEcCtD
Flavoxate—Palpitations—Diphenhydramine—atopic dermatitis	0.00121	0.015	CcSEcCtD
Flavoxate—Skin disorder—Fluocinonide—atopic dermatitis	0.0012	0.015	CcSEcCtD
Flavoxate—Dry mouth—Diphenhydramine—atopic dermatitis	0.00114	0.0142	CcSEcCtD
Flavoxate—Dry mouth—Dimenhydrinate—atopic dermatitis	0.00114	0.0142	CcSEcCtD
Flavoxate—Confusional state—Dimenhydrinate—atopic dermatitis	0.00112	0.014	CcSEcCtD
Flavoxate—Confusional state—Diphenhydramine—atopic dermatitis	0.00112	0.014	CcSEcCtD
Flavoxate—Tachycardia—Dimenhydrinate—atopic dermatitis	0.00109	0.0136	CcSEcCtD
Flavoxate—Tachycardia—Diphenhydramine—atopic dermatitis	0.00109	0.0136	CcSEcCtD
Flavoxate—Skin disorder—Pimecrolimus—atopic dermatitis	0.00105	0.0131	CcSEcCtD
Flavoxate—Tension—Loratadine—atopic dermatitis	0.00103	0.0129	CcSEcCtD
Flavoxate—Nervousness—Loratadine—atopic dermatitis	0.00102	0.0127	CcSEcCtD
Flavoxate—Somnolence—Dimenhydrinate—atopic dermatitis	0.000991	0.0124	CcSEcCtD
Flavoxate—Somnolence—Diphenhydramine—atopic dermatitis	0.000991	0.0124	CcSEcCtD
Flavoxate—Headache—Desonide—atopic dermatitis	0.000956	0.0119	CcSEcCtD
Flavoxate—Palpitations—Loratadine—atopic dermatitis	0.000929	0.0116	CcSEcCtD
Flavoxate—Feeling abnormal—Diphenhydramine—atopic dermatitis	0.000918	0.0115	CcSEcCtD
Flavoxate—Feeling abnormal—Dimenhydrinate—atopic dermatitis	0.000918	0.0115	CcSEcCtD
Flavoxate—Vision blurred—Fluocinolone Acetonide—atopic dermatitis	0.000891	0.0111	CcSEcCtD
Flavoxate—Urticaria—Diphenhydramine—atopic dermatitis	0.000885	0.011	CcSEcCtD
Flavoxate—Urticaria—Dimenhydrinate—atopic dermatitis	0.000885	0.011	CcSEcCtD
Flavoxate—Dry mouth—Loratadine—atopic dermatitis	0.000876	0.0109	CcSEcCtD
Flavoxate—Urticaria—Pimecrolimus—atopic dermatitis	0.000856	0.0107	CcSEcCtD
Flavoxate—Vertigo—Fluocinolone Acetonide—atopic dermatitis	0.000849	0.0106	CcSEcCtD
Flavoxate—Tachycardia—Loratadine—atopic dermatitis	0.000838	0.0104	CcSEcCtD
Flavoxate—Skin disorder—Loratadine—atopic dermatitis	0.000834	0.0104	CcSEcCtD
Flavoxate—Headache—Fluocinonide—atopic dermatitis	0.000774	0.00966	CcSEcCtD
Flavoxate—Somnolence—Loratadine—atopic dermatitis	0.000763	0.00951	CcSEcCtD
Flavoxate—Dry mouth—Mometasone—atopic dermatitis	0.000751	0.00937	CcSEcCtD
Flavoxate—Vomiting—Dimenhydrinate—atopic dermatitis	0.000709	0.00884	CcSEcCtD
Flavoxate—Vomiting—Diphenhydramine—atopic dermatitis	0.000709	0.00884	CcSEcCtD
Flavoxate—Feeling abnormal—Loratadine—atopic dermatitis	0.000707	0.00882	CcSEcCtD
Flavoxate—Tension—Tacrolimus—atopic dermatitis	0.000705	0.00879	CcSEcCtD
Flavoxate—Headache—Diphenhydramine—atopic dermatitis	0.000698	0.00871	CcSEcCtD
Flavoxate—Headache—Dimenhydrinate—atopic dermatitis	0.000698	0.00871	CcSEcCtD
Flavoxate—Nervousness—Tacrolimus—atopic dermatitis	0.000698	0.0087	CcSEcCtD
Flavoxate—Vomiting—Pimecrolimus—atopic dermatitis	0.000685	0.00854	CcSEcCtD
Flavoxate—Vision blurred—Tacrolimus—atopic dermatitis	0.000677	0.00844	CcSEcCtD
Flavoxate—Headache—Pimecrolimus—atopic dermatitis	0.000675	0.00842	CcSEcCtD
Flavoxate—Nausea—Diphenhydramine—atopic dermatitis	0.000662	0.00825	CcSEcCtD
Flavoxate—Nausea—Dimenhydrinate—atopic dermatitis	0.000662	0.00825	CcSEcCtD
Flavoxate—Vertigo—Tacrolimus—atopic dermatitis	0.000645	0.00805	CcSEcCtD
Flavoxate—Leukopenia—Tacrolimus—atopic dermatitis	0.000643	0.00802	CcSEcCtD
Flavoxate—Nausea—Pimecrolimus—atopic dermatitis	0.00064	0.00798	CcSEcCtD
Flavoxate—Palpitations—Tacrolimus—atopic dermatitis	0.000635	0.00792	CcSEcCtD
Flavoxate—Dry mouth—Tacrolimus—atopic dermatitis	0.000598	0.00746	CcSEcCtD
Flavoxate—Confusional state—Tacrolimus—atopic dermatitis	0.000591	0.00737	CcSEcCtD
Flavoxate—Tachycardia—Tacrolimus—atopic dermatitis	0.000572	0.00713	CcSEcCtD
Flavoxate—Skin disorder—Tacrolimus—atopic dermatitis	0.000569	0.0071	CcSEcCtD
Flavoxate—Vomiting—Loratadine—atopic dermatitis	0.000546	0.0068	CcSEcCtD
Flavoxate—Headache—Loratadine—atopic dermatitis	0.000538	0.0067	CcSEcCtD
Flavoxate—Somnolence—Tacrolimus—atopic dermatitis	0.000521	0.0065	CcSEcCtD
Flavoxate—Nausea—Loratadine—atopic dermatitis	0.00051	0.00636	CcSEcCtD
Flavoxate—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00049	0.00612	CcSEcCtD
Flavoxate—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000483	0.00603	CcSEcCtD
Flavoxate—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000483	0.00602	CcSEcCtD
Flavoxate—Vomiting—Mometasone—atopic dermatitis	0.000468	0.00584	CcSEcCtD
Flavoxate—Urticaria—Tacrolimus—atopic dermatitis	0.000466	0.00581	CcSEcCtD
Flavoxate—Headache—Mometasone—atopic dermatitis	0.000461	0.00575	CcSEcCtD
Flavoxate—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000458	0.00571	CcSEcCtD
Flavoxate—Nausea—Mometasone—atopic dermatitis	0.000438	0.00546	CcSEcCtD
Flavoxate—Vision blurred—Prednisolone—atopic dermatitis	0.000432	0.00539	CcSEcCtD
Flavoxate—Vertigo—Prednisolone—atopic dermatitis	0.000412	0.00514	CcSEcCtD
Flavoxate—Vertigo—Hydrocortisone—atopic dermatitis	0.000403	0.00502	CcSEcCtD
Flavoxate—Vertigo—Triamcinolone—atopic dermatitis	0.000379	0.00473	CcSEcCtD
Flavoxate—Vertigo—Methylprednisolone—atopic dermatitis	0.000378	0.00472	CcSEcCtD
Flavoxate—Vomiting—Tacrolimus—atopic dermatitis	0.000373	0.00465	CcSEcCtD
Flavoxate—Headache—Tacrolimus—atopic dermatitis	0.000367	0.00458	CcSEcCtD
Flavoxate—Tachycardia—Prednisolone—atopic dermatitis	0.000365	0.00456	CcSEcCtD
Flavoxate—Tachycardia—Hydrocortisone—atopic dermatitis	0.000357	0.00445	CcSEcCtD
Flavoxate—Skin disorder—Hydrocortisone—atopic dermatitis	0.000355	0.00443	CcSEcCtD
Flavoxate—Dry mouth—Triamcinolone—atopic dermatitis	0.000351	0.00438	CcSEcCtD
Flavoxate—Nausea—Tacrolimus—atopic dermatitis	0.000348	0.00434	CcSEcCtD
Flavoxate—Confusional state—Methylprednisolone—atopic dermatitis	0.000346	0.00432	CcSEcCtD
Flavoxate—Vertigo—Betamethasone—atopic dermatitis	0.000344	0.00429	CcSEcCtD
Flavoxate—Vertigo—Dexamethasone—atopic dermatitis	0.000344	0.00429	CcSEcCtD
Flavoxate—Tachycardia—Triamcinolone—atopic dermatitis	0.000336	0.00419	CcSEcCtD
Flavoxate—Tachycardia—Methylprednisolone—atopic dermatitis	0.000335	0.00418	CcSEcCtD
Flavoxate—Skin disorder—Methylprednisolone—atopic dermatitis	0.000334	0.00416	CcSEcCtD
Flavoxate—Vision blurred—Prednisone—atopic dermatitis	0.000314	0.00392	CcSEcCtD
Flavoxate—Feeling abnormal—Prednisolone—atopic dermatitis	0.000309	0.00385	CcSEcCtD
Flavoxate—Tachycardia—Dexamethasone—atopic dermatitis	0.000305	0.0038	CcSEcCtD
Flavoxate—Tachycardia—Betamethasone—atopic dermatitis	0.000305	0.0038	CcSEcCtD
Flavoxate—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000301	0.00376	CcSEcCtD
Flavoxate—Vertigo—Prednisone—atopic dermatitis	0.0003	0.00374	CcSEcCtD
Flavoxate—Urticaria—Prednisolone—atopic dermatitis	0.000297	0.00371	CcSEcCtD
Flavoxate—Urticaria—Hydrocortisone—atopic dermatitis	0.000291	0.00362	CcSEcCtD
Flavoxate—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000284	0.00354	CcSEcCtD
Flavoxate—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000283	0.00353	CcSEcCtD
Flavoxate—Urticaria—Triamcinolone—atopic dermatitis	0.000274	0.00341	CcSEcCtD
Flavoxate—Urticaria—Methylprednisolone—atopic dermatitis	0.000273	0.0034	CcSEcCtD
Flavoxate—Tachycardia—Prednisone—atopic dermatitis	0.000266	0.00331	CcSEcCtD
Flavoxate—Skin disorder—Prednisone—atopic dermatitis	0.000264	0.0033	CcSEcCtD
Flavoxate—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000257	0.00321	CcSEcCtD
Flavoxate—Feeling abnormal—Betamethasone—atopic dermatitis	0.000257	0.00321	CcSEcCtD
Flavoxate—Urticaria—Dexamethasone—atopic dermatitis	0.000248	0.0031	CcSEcCtD
Flavoxate—Urticaria—Betamethasone—atopic dermatitis	0.000248	0.0031	CcSEcCtD
Flavoxate—Headache—Prednisolone—atopic dermatitis	0.000235	0.00293	CcSEcCtD
Flavoxate—Vomiting—Hydrocortisone—atopic dermatitis	0.000233	0.0029	CcSEcCtD
Flavoxate—Headache—Hydrocortisone—atopic dermatitis	0.000229	0.00286	CcSEcCtD
Flavoxate—Feeling abnormal—Prednisone—atopic dermatitis	0.000224	0.0028	CcSEcCtD
Flavoxate—Nausea—Prednisolone—atopic dermatitis	0.000222	0.00277	CcSEcCtD
Flavoxate—Vomiting—Triamcinolone—atopic dermatitis	0.000219	0.00273	CcSEcCtD
Flavoxate—Vomiting—Methylprednisolone—atopic dermatitis	0.000218	0.00272	CcSEcCtD
Flavoxate—Nausea—Hydrocortisone—atopic dermatitis	0.000217	0.00271	CcSEcCtD
Flavoxate—Urticaria—Prednisone—atopic dermatitis	0.000216	0.0027	CcSEcCtD
Flavoxate—Headache—Triamcinolone—atopic dermatitis	0.000216	0.00269	CcSEcCtD
Flavoxate—Headache—Methylprednisolone—atopic dermatitis	0.000215	0.00268	CcSEcCtD
Flavoxate—Nausea—Triamcinolone—atopic dermatitis	0.000205	0.00255	CcSEcCtD
Flavoxate—Nausea—Methylprednisolone—atopic dermatitis	0.000204	0.00254	CcSEcCtD
Flavoxate—Vomiting—Dexamethasone—atopic dermatitis	0.000199	0.00248	CcSEcCtD
Flavoxate—Vomiting—Betamethasone—atopic dermatitis	0.000199	0.00248	CcSEcCtD
Flavoxate—Headache—Betamethasone—atopic dermatitis	0.000196	0.00244	CcSEcCtD
Flavoxate—Headache—Dexamethasone—atopic dermatitis	0.000196	0.00244	CcSEcCtD
Flavoxate—Nausea—Dexamethasone—atopic dermatitis	0.000186	0.00231	CcSEcCtD
Flavoxate—Nausea—Betamethasone—atopic dermatitis	0.000186	0.00231	CcSEcCtD
Flavoxate—Vomiting—Prednisone—atopic dermatitis	0.000173	0.00216	CcSEcCtD
Flavoxate—Headache—Prednisone—atopic dermatitis	0.00017	0.00213	CcSEcCtD
Flavoxate—Nausea—Prednisone—atopic dermatitis	0.000162	0.00202	CcSEcCtD
Flavoxate—CHRM2—G alpha (i) signalling events—CCR5—atopic dermatitis	7.64e-05	0.0011	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—NPS—atopic dermatitis	7.62e-05	0.0011	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—TAC1—atopic dermatitis	7.62e-05	0.0011	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—NPS—atopic dermatitis	7.52e-05	0.00108	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—TAC1—atopic dermatitis	7.52e-05	0.00108	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—STAT6—atopic dermatitis	7.52e-05	0.00108	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—CXCR3—atopic dermatitis	7.47e-05	0.00108	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—CXCL8—atopic dermatitis	7.46e-05	0.00108	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCL27—atopic dermatitis	7.44e-05	0.00107	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCL11—atopic dermatitis	7.4e-05	0.00107	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CMA1—atopic dermatitis	7.4e-05	0.00107	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—CCL5—atopic dermatitis	7.39e-05	0.00107	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—CXCR3—atopic dermatitis	7.37e-05	0.00106	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCL27—atopic dermatitis	7.35e-05	0.00106	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CCL5—atopic dermatitis	7.34e-05	0.00106	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NGF—atopic dermatitis	7.32e-05	0.00106	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—CCR5—atopic dermatitis	7.3e-05	0.00105	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—CXCL8—atopic dermatitis	7.28e-05	0.00105	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—CXCL10—atopic dermatitis	7.22e-05	0.00104	CbGpPWpGaD
Flavoxate—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	7.18e-05	0.00104	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—IL2—atopic dermatitis	7.13e-05	0.00103	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CCR5—atopic dermatitis	7.12e-05	0.00103	CbGpPWpGaD
Flavoxate—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	7.09e-05	0.00102	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—CCL5—atopic dermatitis	7.05e-05	0.00102	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TAC1—atopic dermatitis	7.01e-05	0.00101	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NPS—atopic dermatitis	7.01e-05	0.00101	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—CCR5—atopic dermatitis	7e-05	0.00101	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—IL2—atopic dermatitis	6.96e-05	0.001	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—STAT6—atopic dermatitis	6.96e-05	0.001	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CXCR3—atopic dermatitis	6.88e-05	0.000992	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCR3—atopic dermatitis	6.85e-05	0.000988	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—CCL5—atopic dermatitis	6.84e-05	0.000986	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	6.83e-05	0.000984	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NGF—atopic dermatitis	6.8e-05	0.000981	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—CXCL8—atopic dermatitis	6.77e-05	0.000976	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NFKBIA—atopic dermatitis	6.77e-05	0.000976	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NFKBIA—atopic dermatitis	6.77e-05	0.000976	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	6.74e-05	0.000972	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—CCL5—atopic dermatitis	6.71e-05	0.000968	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCL17—atopic dermatitis	6.68e-05	0.000963	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—CCR5—atopic dermatitis	6.66e-05	0.00096	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CCR5—atopic dermatitis	6.62e-05	0.000954	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCL17—atopic dermatitis	6.59e-05	0.00095	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL5—atopic dermatitis	6.52e-05	0.00094	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCR3—atopic dermatitis	6.52e-05	0.00094	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—IL2—atopic dermatitis	6.47e-05	0.000933	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	6.41e-05	0.000924	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—CCR5—atopic dermatitis	6.35e-05	0.000916	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—CCL5—atopic dermatitis	6.21e-05	0.000896	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—CCR5—atopic dermatitis	6.16e-05	0.000889	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.15e-05	0.000887	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	6.15e-05	0.000886	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TAC1—atopic dermatitis	6.11e-05	0.000881	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NPS—atopic dermatitis	6.11e-05	0.000881	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.07e-05	0.000876	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—CCR5—atopic dermatitis	6.05e-05	0.000872	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—CXCL10—atopic dermatitis	6.04e-05	0.000871	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCR3—atopic dermatitis	6.03e-05	0.00087	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NFKBIA—atopic dermatitis	6.03e-05	0.00087	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CXCR3—atopic dermatitis	5.99e-05	0.000863	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—CXCL10—atopic dermatitis	5.96e-05	0.00086	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TAC1—atopic dermatitis	5.81e-05	0.000838	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NPS—atopic dermatitis	5.81e-05	0.000838	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CXCR3—atopic dermatitis	5.7e-05	0.000822	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL5—atopic dermatitis	5.68e-05	0.000819	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NFKBIA—atopic dermatitis	5.61e-05	0.000809	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—CCR5—atopic dermatitis	5.6e-05	0.000807	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CXCL10—atopic dermatitis	5.56e-05	0.000802	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL5—atopic dermatitis	5.4e-05	0.000779	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCL11—atopic dermatitis	5.38e-05	0.000776	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NPS—atopic dermatitis	5.38e-05	0.000775	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TAC1—atopic dermatitis	5.38e-05	0.000775	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCL11—atopic dermatitis	5.31e-05	0.000766	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FCER2—atopic dermatitis	5.31e-05	0.000765	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CXCR3—atopic dermatitis	5.27e-05	0.000761	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FCER2—atopic dermatitis	5.24e-05	0.000755	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—CCL5—atopic dermatitis	5.2e-05	0.00075	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—CCL5—atopic dermatitis	5.13e-05	0.00074	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL5—atopic dermatitis	5e-05	0.000721	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL22—atopic dermatitis	4.93e-05	0.000711	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL22—atopic dermatitis	4.87e-05	0.000702	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—CXCL8—atopic dermatitis	4.86e-05	0.000701	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CXCL10—atopic dermatitis	4.84e-05	0.000698	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CCR3—atopic dermatitis	4.83e-05	0.000697	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CXCL8—atopic dermatitis	4.83e-05	0.000696	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CXCL8—atopic dermatitis	4.83e-05	0.000696	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CCL5—atopic dermatitis	4.79e-05	0.00069	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CCR3—atopic dermatitis	4.77e-05	0.000688	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—CCR5—atopic dermatitis	4.68e-05	0.000675	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—MAPK8—atopic dermatitis	4.66e-05	0.000672	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—IL2—atopic dermatitis	4.64e-05	0.00067	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—CCR5—atopic dermatitis	4.62e-05	0.000667	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—CXCL8—atopic dermatitis	4.62e-05	0.000666	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IL2—atopic dermatitis	4.61e-05	0.000665	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IL2—atopic dermatitis	4.61e-05	0.000665	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CXCL10—atopic dermatitis	4.61e-05	0.000664	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—IL6—atopic dermatitis	4.59e-05	0.000662	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—IL6—atopic dermatitis	4.59e-05	0.000662	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	4.46e-05	0.000643	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NGF—atopic dermatitis	4.43e-05	0.000639	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—CXCL8—atopic dermatitis	4.41e-05	0.000636	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	4.4e-05	0.000634	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	4.39e-05	0.000633	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL27—atopic dermatitis	4.34e-05	0.000626	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCR3—atopic dermatitis	4.33e-05	0.000624	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CCR5—atopic dermatitis	4.31e-05	0.000622	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	4.31e-05	0.000621	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	4.31e-05	0.000621	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CXCL8—atopic dermatitis	4.3e-05	0.00062	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CXCL10—atopic dermatitis	4.26e-05	0.000615	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—TAC1—atopic dermatitis	4.25e-05	0.000613	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—NPS—atopic dermatitis	4.25e-05	0.000613	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MAPK8—atopic dermatitis	4.25e-05	0.000612	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MAPK8—atopic dermatitis	4.25e-05	0.000612	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—CXCL8—atopic dermatitis	4.23e-05	0.00061	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	4.22e-05	0.000609	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—IL2—atopic dermatitis	4.22e-05	0.000608	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CXCR3—atopic dermatitis	4.17e-05	0.000601	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCL5—atopic dermatitis	4.17e-05	0.000601	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IL2—atopic dermatitis	4.11e-05	0.000593	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—IL6—atopic dermatitis	4.09e-05	0.00059	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—IL2—atopic dermatitis	4.04e-05	0.000583	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.03e-05	0.000581	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	4e-05	0.000577	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CXCL8—atopic dermatitis	4e-05	0.000577	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCL5—atopic dermatitis	3.97e-05	0.000572	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—IL5—atopic dermatitis	3.95e-05	0.00057	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	3.94e-05	0.000569	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	3.91e-05	0.000564	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	3.91e-05	0.000564	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL17—atopic dermatitis	3.89e-05	0.000561	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—TAC1—atopic dermatitis	3.86e-05	0.000557	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—NPS—atopic dermatitis	3.86e-05	0.000557	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NGF—atopic dermatitis	3.86e-05	0.000556	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—IL2—atopic dermatitis	3.85e-05	0.000555	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—CXCL8—atopic dermatitis	3.84e-05	0.000554	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	3.83e-05	0.000553	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL2—atopic dermatitis	3.82e-05	0.000551	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—IL6—atopic dermatitis	3.8e-05	0.000549	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCR3—atopic dermatitis	3.78e-05	0.000546	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MAPK8—atopic dermatitis	3.78e-05	0.000546	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCR5—atopic dermatitis	3.75e-05	0.000541	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—CXCL8—atopic dermatitis	3.73e-05	0.000537	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.72e-05	0.000536	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NGF—atopic dermatitis	3.67e-05	0.00053	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL2—atopic dermatitis	3.67e-05	0.000529	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.67e-05	0.000529	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCL5—atopic dermatitis	3.67e-05	0.000529	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—CXCL8—atopic dermatitis	3.66e-05	0.000527	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NFKBIA—atopic dermatitis	3.66e-05	0.000527	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	3.63e-05	0.000524	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3.6e-05	0.000519	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL5—atopic dermatitis	3.59e-05	0.000517	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCR5—atopic dermatitis	3.57e-05	0.000515	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—IL2—atopic dermatitis	3.56e-05	0.000513	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MAPK8—atopic dermatitis	3.52e-05	0.000507	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	3.51e-05	0.000507	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL2—atopic dermatitis	3.49e-05	0.000504	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KIF3A—atopic dermatitis	3.47e-05	0.0005	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	3.41e-05	0.000492	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NGF—atopic dermatitis	3.4e-05	0.00049	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—CXCL8—atopic dermatitis	3.38e-05	0.000488	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CXCL10—atopic dermatitis	3.37e-05	0.000486	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCR5—atopic dermatitis	3.31e-05	0.000477	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL2—atopic dermatitis	3.23e-05	0.000466	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NFKBIA—atopic dermatitis	3.18e-05	0.000459	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	3.18e-05	0.000458	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	3.18e-05	0.000458	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL11—atopic dermatitis	3.14e-05	0.000453	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CMA1—atopic dermatitis	3.14e-05	0.000453	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	3.1e-05	0.000447	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCL10—atopic dermatitis	3.06e-05	0.000441	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NFKBIA—atopic dermatitis	3.03e-05	0.000437	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	2.99e-05	0.000431	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	2.98e-05	0.000429	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—STAT6—atopic dermatitis	2.95e-05	0.000425	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	2.94e-05	0.000424	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CCL5—atopic dermatitis	2.9e-05	0.000418	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	2.83e-05	0.000408	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.82e-05	0.000407	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NFKBIA—atopic dermatitis	2.8e-05	0.000404	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—CXCL8—atopic dermatitis	2.79e-05	0.000403	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IL6—atopic dermatitis	2.71e-05	0.000391	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IL6—atopic dermatitis	2.71e-05	0.000391	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	2.67e-05	0.000385	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	2.65e-05	0.000382	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCL5—atopic dermatitis	2.63e-05	0.00038	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CCR5—atopic dermatitis	2.61e-05	0.000377	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CXCL8—atopic dermatitis	2.61e-05	0.000376	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	2.59e-05	0.000374	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCR3—atopic dermatitis	2.56e-05	0.000369	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL2—atopic dermatitis	2.49e-05	0.000359	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—IL6—atopic dermatitis	2.48e-05	0.000357	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IL6—atopic dermatitis	2.42e-05	0.000349	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	2.4e-05	0.000347	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	2.37e-05	0.000342	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NPS—atopic dermatitis	2.31e-05	0.000333	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	2.31e-05	0.000333	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MAPK8—atopic dermatitis	2.29e-05	0.000331	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NPS—atopic dermatitis	2.28e-05	0.000329	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	2.28e-05	0.000329	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CXCL8—atopic dermatitis	2.27e-05	0.000327	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	2.26e-05	0.000327	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL6—atopic dermatitis	2.25e-05	0.000324	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	2.24e-05	0.000322	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL2—atopic dermatitis	2.17e-05	0.000313	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CXCL8—atopic dermatitis	2.16e-05	0.000311	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL6—atopic dermatitis	2.16e-05	0.000311	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL5—atopic dermatitis	2.15e-05	0.00031	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL5—atopic dermatitis	2.12e-05	0.000306	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL2—atopic dermatitis	2.06e-05	0.000298	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL6—atopic dermatitis	2.05e-05	0.000296	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CXCL8—atopic dermatitis	2e-05	0.000288	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MAPK8—atopic dermatitis	2e-05	0.000288	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL2—atopic dermatitis	1.91e-05	0.000275	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL6—atopic dermatitis	1.9e-05	0.000274	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MAPK8—atopic dermatitis	1.9e-05	0.000274	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	1.83e-05	0.000264	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	1.81e-05	0.000261	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MAPK8—atopic dermatitis	1.76e-05	0.000254	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.6e-05	0.000231	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.58e-05	0.000228	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	1.58e-05	0.000227	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	1.56e-05	0.000224	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	1.53e-05	0.000221	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	1.51e-05	0.000218	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL6—atopic dermatitis	1.46e-05	0.000211	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NGF—atopic dermatitis	1.46e-05	0.00021	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	1.45e-05	0.00021	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NGF—atopic dermatitis	1.44e-05	0.000208	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	1.43e-05	0.000207	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	1.42e-05	0.000205	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	1.4e-05	0.000202	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	1.39e-05	0.0002	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	1.37e-05	0.000198	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL6—atopic dermatitis	1.27e-05	0.000184	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL6—atopic dermatitis	1.21e-05	0.000175	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	1.2e-05	0.000174	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	1.19e-05	0.000171	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL6—atopic dermatitis	1.12e-05	0.000162	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	8.58e-06	0.000124	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	8.47e-06	0.000122	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL2—atopic dermatitis	8.2e-06	0.000118	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	8.16e-06	0.000118	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL2—atopic dermatitis	8.1e-06	0.000117	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	8.06e-06	0.000116	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	7.55e-06	0.000109	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	7.45e-06	0.000107	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6—atopic dermatitis	4.82e-06	6.95e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6—atopic dermatitis	4.76e-06	6.86e-05	CbGpPWpGaD
